DE3875267T2 - Heptaenantibiotikum, v-28-3m. - Google Patents

Heptaenantibiotikum, v-28-3m.

Info

Publication number
DE3875267T2
DE3875267T2 DE8888103207T DE3875267T DE3875267T2 DE 3875267 T2 DE3875267 T2 DE 3875267T2 DE 8888103207 T DE8888103207 T DE 8888103207T DE 3875267 T DE3875267 T DE 3875267T DE 3875267 T2 DE3875267 T2 DE 3875267T2
Authority
DE
Germany
Prior art keywords
positive
spectrum
nmr spectrum
sulphuric acid
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888103207T
Other languages
German (de)
English (en)
Other versions
DE3875267D1 (de
Inventor
Koichi Ishii
Yasuo Komoda
Ryosaku Noumi
Masahiko Okunishi
Hiroshiro Shibai
Yasunori Yokogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE3875267D1 publication Critical patent/DE3875267D1/de
Publication of DE3875267T2 publication Critical patent/DE3875267T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8888103207T 1987-03-06 1988-03-02 Heptaenantibiotikum, v-28-3m. Expired - Lifetime DE3875267T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62051570A JPS63218686A (ja) 1987-03-06 1987-03-06 新規ヘプタエンｖ−２８−３ｍ

Publications (2)

Publication Number Publication Date
DE3875267D1 DE3875267D1 (de) 1992-11-19
DE3875267T2 true DE3875267T2 (de) 1993-05-19

Family

ID=12890620

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888103207T Expired - Lifetime DE3875267T2 (de) 1987-03-06 1988-03-02 Heptaenantibiotikum, v-28-3m.

Country Status (4)

Country Link
US (1) US5023079A (https=)
EP (1) EP0285805B1 (https=)
JP (1) JPS63218686A (https=)
DE (1) DE3875267T2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401836A (en) * 1992-07-16 1995-03-28 Pioneer Hi-Bre International, Inc. Brassica regulatory sequence for root-specific or root-abundant gene expression
AU7549198A (en) 1997-06-03 1998-12-21 Ajinomoto Co., Inc. Process for preparing antifungal v-28-3m
WO1999014225A1 (fr) 1997-09-12 1999-03-25 Ajinomoto Co., Inc. Produit d'addition d'acetone pour agent antifongique v-28-3m

Also Published As

Publication number Publication date
EP0285805A2 (en) 1988-10-12
EP0285805A3 (en) 1990-05-30
US5023079A (en) 1991-06-11
JPS63218686A (ja) 1988-09-12
JPH0453878B2 (https=) 1992-08-27
EP0285805B1 (en) 1992-10-14
DE3875267D1 (de) 1992-11-19

Similar Documents

Publication Publication Date Title
DE69021176T2 (de) Polypeptid und Verfahren zu dessen Herstellung.
EP0362520A2 (de) Ein neues Antibiotikum, Mersacidin, ein Verfahren zur seiner Herstellung und seine Verwendung als Arzneimittel
DD238068A5 (de) Verfahren zur herstellung von derivaten der cyclopeptidantibiotika a-21978 c
DE3875267T2 (de) Heptaenantibiotikum, v-28-3m.
DE2715255B2 (de) Anthracyclinglykoside MA 144-M1 und MA 144-M2 und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE69114252T2 (de) Reveromycin-a, herstellung und verwendung als antitumormittel sowie als fungizid.
CH467336A (de) Verfahren zur Herstellung eines neuen Antibiotikums
DE3687170T2 (de) Antitumorale antibiotika und deren herstellung.
DE2928373C2 (de) Antibiotika KA-7038I bis KA-7038VII, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibiotische Mittel
DE69206858T2 (de) Verbindung UCA1064-B
DE3149608C2 (https=)
DE3786795T2 (de) Antibiotikum yi-hu3 und herstellungsverfahren.
DE2418349A1 (de) Fortimicin b, verfahren zu seiner herstellung, mikroorganismen zur durchfuehrung des verfahrens und arzneimittel
DE69001554T2 (de) Polyzyklische Verbindungen und deren Herstellung.
DE3611168A1 (de) Neue tpi genannte chemische verbindungen, deren herstellung und deren verwendung als physiologisch wirksame substanzen
EP0296545B1 (de) Ein neues Antibiotikum, Fumifungin, ein mikrobielles Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel
DE69005899T2 (de) Karzinostatisches oder antitumorales Antibiotikum, Conagenin, seine Herstellung und seine Verwendungen.
DE69316903T2 (de) Saintopin derivate
DE3881566T2 (de) Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE69111119T2 (de) Durch Fermentation hergestellte Polysaccharide.
DE3782199T2 (de) Biologisch aktive peptide tan-866.
DE3882654T2 (de) Enzymhemmer und Methode zu dessen Herstellung.
DE69902537T2 (de) Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung
DE2746252A1 (de) Antibiotikum c-15003 enthaltendes arzneimittel zur behandlung von tumore aufweisenden warmbluetern
DE4211056C1 (en) Spiran heterocyclic deriv. for controlling fungi and bacteria uncontrollable - prepd. by fermenting Sorangium e.g. Polyangium cellulosum in medium contg. carbon and nitrogen sources and mineral salts in adsorber resin, and eluting

Legal Events

Date Code Title Description
8364 No opposition during term of opposition